Business
Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference
DUBLIN--(BUSINESS WIRE)-- Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will provide a corporate overview and
About this update from Alkermes Plc
DUBLIN --(BUSINESS WIRE)-- Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops , will provide a corporate overview and update at the 44th Annual J.P. Morgan Healthcare Conference . The presentation will take place on Tuesday, Jan. 13, 2026 at 10:30 a.m. PST ( 1:30 p.m. EST / 6:30 p.m. GMT ). The live webcast may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days. About Alkermes plc Alkermes plc (Nasdaq: ALKS), a mid-cap growth and value equity, is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders, including narcolepsy and idiopathic hypersomnia. Headquartered in Ireland , Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio . For more information, please visit Alkermes’ website at www.alkermes.com . View source version on businesswire.com : https://www.businesswire.com/news/home/20251229760927/en/ Alkermes Contact: Jamie Constantine Investor Relations +1 781 873 2402 Source: Alkermes plc